Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate

Keiko Yamamura, Tsunehisa Sakurai, Kohji Yano, Toshitaka Nabeshima, Toshihisa Yotsuyanagi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We designed a model vascular prosthesis consisting of expanded polytetrafluoroethylene (Gore Tex®) loaded with basic fibroblast growth factor (bFGF), and studied its in vivo bFGF release behavior. To control the release rate of bFGF, biodegradable hydroxypropylchitosan acetate (HPCHA) was also incorporated into the Gore Tex® disks with bFGF. HPCHA was dissolved in bFGF solution (180 μg/ml) at a concentration of 4% (wt/vol). A Gore Tex® tube was cut into a length of about 5 cm and one end was sealed with a vascular clamp. The tube was then filled with resulting solution under appropriate pressure until the solvents seeped through the pores. The tube loaded with BFGF solution was freeze‐dried and was cut into disks (0.75 cm in diameter). bFGF content in a HPCHA‐free Gore disk was 2.05 ± 0.32 μg (SE, n = 5). BFGF content in a HPCHA Gore disk was 2.71 ± 0.41 μg (SE, n = 5). In an in vivo study in which the bFGF loaded Gore Tex® disk was implanted in rabbit skin pockets, almost 100% of bFGF from HPCHA‐free disks was released within 24 h, whereas some 60% remained after 24 h in the HPCHA‐loaded disks. HPCHA is a useful biodegradable carrier for controlling the release rate of the drug from the synthetic vascular prosthesis. © 1995 John Wiley & Sons, Inc.

Original languageEnglish
Pages (from-to)203-206
Number of pages4
JournalJournal of Biomedical Materials Research
Volume29
Issue number2
DOIs
Publication statusPublished - 01-01-1995
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 2
Fibroblasts
Acetates
Prostheses and Implants
Intercellular Signaling Peptides and Proteins
Clamping devices
Polytetrafluoroethylene
Polytetrafluoroethylenes
Skin
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{4049c8af944d4ff9acd219f4fdf3eeed,
title = "Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate",
abstract = "We designed a model vascular prosthesis consisting of expanded polytetrafluoroethylene (Gore Tex{\circledR}) loaded with basic fibroblast growth factor (bFGF), and studied its in vivo bFGF release behavior. To control the release rate of bFGF, biodegradable hydroxypropylchitosan acetate (HPCHA) was also incorporated into the Gore Tex{\circledR} disks with bFGF. HPCHA was dissolved in bFGF solution (180 μg/ml) at a concentration of 4{\%} (wt/vol). A Gore Tex{\circledR} tube was cut into a length of about 5 cm and one end was sealed with a vascular clamp. The tube was then filled with resulting solution under appropriate pressure until the solvents seeped through the pores. The tube loaded with BFGF solution was freeze‐dried and was cut into disks (0.75 cm in diameter). bFGF content in a HPCHA‐free Gore disk was 2.05 ± 0.32 μg (SE, n = 5). BFGF content in a HPCHA Gore disk was 2.71 ± 0.41 μg (SE, n = 5). In an in vivo study in which the bFGF loaded Gore Tex{\circledR} disk was implanted in rabbit skin pockets, almost 100{\%} of bFGF from HPCHA‐free disks was released within 24 h, whereas some 60{\%} remained after 24 h in the HPCHA‐loaded disks. HPCHA is a useful biodegradable carrier for controlling the release rate of the drug from the synthetic vascular prosthesis. {\circledC} 1995 John Wiley & Sons, Inc.",
author = "Keiko Yamamura and Tsunehisa Sakurai and Kohji Yano and Toshitaka Nabeshima and Toshihisa Yotsuyanagi",
year = "1995",
month = "1",
day = "1",
doi = "10.1002/jbm.820290210",
language = "English",
volume = "29",
pages = "203--206",
journal = "Journal of Biomedical Materials Research",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "2",

}

Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate. / Yamamura, Keiko; Sakurai, Tsunehisa; Yano, Kohji; Nabeshima, Toshitaka; Yotsuyanagi, Toshihisa.

In: Journal of Biomedical Materials Research, Vol. 29, No. 2, 01.01.1995, p. 203-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate

AU - Yamamura, Keiko

AU - Sakurai, Tsunehisa

AU - Yano, Kohji

AU - Nabeshima, Toshitaka

AU - Yotsuyanagi, Toshihisa

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We designed a model vascular prosthesis consisting of expanded polytetrafluoroethylene (Gore Tex®) loaded with basic fibroblast growth factor (bFGF), and studied its in vivo bFGF release behavior. To control the release rate of bFGF, biodegradable hydroxypropylchitosan acetate (HPCHA) was also incorporated into the Gore Tex® disks with bFGF. HPCHA was dissolved in bFGF solution (180 μg/ml) at a concentration of 4% (wt/vol). A Gore Tex® tube was cut into a length of about 5 cm and one end was sealed with a vascular clamp. The tube was then filled with resulting solution under appropriate pressure until the solvents seeped through the pores. The tube loaded with BFGF solution was freeze‐dried and was cut into disks (0.75 cm in diameter). bFGF content in a HPCHA‐free Gore disk was 2.05 ± 0.32 μg (SE, n = 5). BFGF content in a HPCHA Gore disk was 2.71 ± 0.41 μg (SE, n = 5). In an in vivo study in which the bFGF loaded Gore Tex® disk was implanted in rabbit skin pockets, almost 100% of bFGF from HPCHA‐free disks was released within 24 h, whereas some 60% remained after 24 h in the HPCHA‐loaded disks. HPCHA is a useful biodegradable carrier for controlling the release rate of the drug from the synthetic vascular prosthesis. © 1995 John Wiley & Sons, Inc.

AB - We designed a model vascular prosthesis consisting of expanded polytetrafluoroethylene (Gore Tex®) loaded with basic fibroblast growth factor (bFGF), and studied its in vivo bFGF release behavior. To control the release rate of bFGF, biodegradable hydroxypropylchitosan acetate (HPCHA) was also incorporated into the Gore Tex® disks with bFGF. HPCHA was dissolved in bFGF solution (180 μg/ml) at a concentration of 4% (wt/vol). A Gore Tex® tube was cut into a length of about 5 cm and one end was sealed with a vascular clamp. The tube was then filled with resulting solution under appropriate pressure until the solvents seeped through the pores. The tube loaded with BFGF solution was freeze‐dried and was cut into disks (0.75 cm in diameter). bFGF content in a HPCHA‐free Gore disk was 2.05 ± 0.32 μg (SE, n = 5). BFGF content in a HPCHA Gore disk was 2.71 ± 0.41 μg (SE, n = 5). In an in vivo study in which the bFGF loaded Gore Tex® disk was implanted in rabbit skin pockets, almost 100% of bFGF from HPCHA‐free disks was released within 24 h, whereas some 60% remained after 24 h in the HPCHA‐loaded disks. HPCHA is a useful biodegradable carrier for controlling the release rate of the drug from the synthetic vascular prosthesis. © 1995 John Wiley & Sons, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0029239559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029239559&partnerID=8YFLogxK

U2 - 10.1002/jbm.820290210

DO - 10.1002/jbm.820290210

M3 - Article

VL - 29

SP - 203

EP - 206

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 0021-9304

IS - 2

ER -